Physician profile
Marcus Jamil
NPI 1063948982
$102,755.19
in general payments reported to CMS, 2019-2025
7 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.16 · 2020: $59.21 · 2021: $154 · 2022: $50K · 2023: $52K · 2024: $199 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Travel and Lodging: $1,243 · Food and Beverage: $847 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Travel and Lodging | $1,242.91 |
| Food and Beverage | $847.04 |
| Education | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $102,404.29 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Coloplast Corp | $115.50 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $112.04 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Conmed Corporation | $44.51 | 2020 | |
| Endo USA, INC. | $44.35 | 2025 | Xiaflex |
| Myovant Sciences INC. | $20.78 | 2021 | |
| Tolmar, INC. | $13.72 | 2025 | Jatenzo, Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Jamil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.